Cognitive · Cognitive peptide (research)
Dihexa
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Also known as
- dihexapeptide, pnb-0408
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What Dihexa is studied for
- Synaptogenesis (research)
- Cognitive support (research)
- Neurogenesis research (research)
Mechanism of action
Dihexa is being studied in the cognitive category. Investigational nootropic studied for synaptogenesis and cognition. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Dihexa?
Dihexa is a cognitive peptide. Investigational nootropic studied for synaptogenesis and cognition.
What is Dihexa studied for?
Published research has examined Dihexa for synaptogenesis, cognitive support, neurogenesis research. Human clinical evidence varies by indication.
Is Dihexa FDA-approved?
No. Dihexa is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Dihexa used in research?
Protocols vary by study. Dihexa is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Dihexa is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the Dihexa protocol stack
Research protocols commonly pair Dihexa with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Cognitive
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal
